Jubilant Ingrevia Revenue and Competitors

IND

Location

N/A

Total Funding

Industry

Estimated Revenue & Valuation

  • Jubilant Ingrevia's estimated annual revenue is currently $205.5M per year.(i)
  • Jubilant Ingrevia's estimated revenue per employee is $140,000

Employee Data

  • Jubilant Ingrevia has 1468 Employees.(i)
  • Jubilant Ingrevia grew their employee count by 21% last year.

Jubilant Ingrevia's People

NameTitleEmail/Phone
1
Chief Digital & Information Officer (CDIO)Reveal Email/Phone
2
President & CFOReveal Email/Phone
3
Chief Operations & Whole Time Director (WTD)Reveal Email/Phone
4
Cluster Head (AVP)Reveal Email/Phone
5
SVPReveal Email/Phone
6
Factory Medical OfficerReveal Email/Phone
7
Head LogisticsReveal Email/Phone
8
Senior OfficerReveal Email/Phone
9
Head Product Management & StrategyReveal Email/Phone
10
Head Investor RelationsReveal Email/Phone

What Is Jubilant Ingrevia?

Ingrevia is born out of a union of ‘Ingredients' and ‘Life' (“Vie” in French). Jubilant is committed to Protect, Enhance and Advance all forms of life – human, animal and plant, by offering high quality and innovative life science ingredients. Jubilant Ingrevia Limited, a global integrated Life Science products and Innovative Solutions provider is focused on bringing value to its stakeholders in a sustainable manner. A science active company with five state-of-the-art manufacturing facilities and R&D centers in India. Through its businesses of Specialty Chemicals, Nutrition & Health Solutions and Life Science Chemicals it is serving fast-growing and diverse industries such as Pharmaceuticals, Agrochemicals, Nutrition, Consumer and Industrial applications.

keywords:N/A

N/A

Total Funding

1468

Number of Employees

$205.5M

Revenue (est)

21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Jubilant Ingrevia News

2022-04-17 - Alpha Picoline Market Size, Scope And Forecast | Leading ...

Jubilant Ingrevia, Vertellus, Resonance Specialties, Jiangsu Zhongbang Pharmaceutical. Alpha Picoline Market Segmentation:.

2022-04-17 - Jubilant Ingrevia zooms 6% on bagging Rs 270 crore specialty chemicals contract

Jubilant Ingrevia's scrip rose to a high of Rs 522 as against Rs 492 at previous close on the BSE. Through the contract the company will supply...

2022-04-17 - Jubilant Ingrevia soars on winning Rs 270-cr CDMO contract

Jubilant Ingrevia jumped 5.21% to Rs 517.65 after the company bagged a CDMO contract for an estimated value of Rs 270 crore in the specialty...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$273.3M1470-26%$13.8M
#2
$358.1M1470N/AN/A
#3
$298.6M147112%N/A
#4
$453.7M147317%N/A
#5
$433.4M14741%$243M